All Stories

  1. Interferon-γ ELISPOT as a Biomarker of Treatment Efficacy in Latent Tuberculosis Infection

    Article • American Review of Respiratory Disease, February 2013, American Thoracic Society

    Abdulrahmah S Hammond, Moses Lugos

  2. Failure to Recognize Nontuberculous Mycobacteria Leads to Misdiagnosis of Chronic Pulmonary Tuberculosis

    Article • PLoS ONE, May 2012, PLOS

    Abdulrahmah S Hammond

  3. Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

    Article • PLoS ONE, February 2011, PLOS

    Abdulrahmah S Hammond

  4. Decay Kinetics of an Interferon Gamma Release Assay with Anti-Tuberculosis Therapy in Newly Diagnosed Tuberculosis Cases

    Article • PLoS ONE, September 2010, PLOS

    Abdulrahmah S Hammond, Moses Lugos

  5. Commercial Interferon Gamma Release Assays Compared to the Tuberculin Skin Test for Diagnosis of Latent Mycobacterium tuberculosis Infection in Childhood Contacts in the Gambia

    Article • The Pediatric Infectious Disease Journal, May 2010, Wolters Kluwer Health

    Abdulrahmah S Hammond, Moses Lugos

  6. Immunogenicity of antigens from the TbD1 region present in M. africanum and missing from "modern" M. tuberculosis: a cross- sectional study

    Article • BMC Infectious Diseases, January 2010, Springer Science + Business Media

    Abdulrahmah S Hammond

  7. Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

    Article • PLoS ONE, August 2008, PLOS

    Abdulrahmah S Hammond

  8. Mycobacterial T Cell Responses in HIV‐Infected Patients with Advanced Immunosuppression

    Article • The Journal of Infectious Diseases, January 2008, Oxford University Press (OUP)

    Abdulrahmah S Hammond

  9. ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active disease

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, July 2007, Oxford University Press (OUP)

    Abdulrahmah S Hammond

  10. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia

    Article • BMC Infectious Diseases, January 2007, Springer Science + Business Media

    Abdulrahmah S Hammond, Moses Lugos

  11. ESAT-6/CFP-10 Fusion Protein and Peptides for Optimal Diagnosis of Mycobacterium tuberculosis Infection by Ex Vivo Enzyme-Linked Immunospot Assay in The Gambia

    Article • Journal of Clinical Microbiology, May 2005, ASM Journals

    Abdulrahmah S Hammond

  12. White blood cell responses are widespread in the pathogen that causes tuberculosis in humans.

    Article • Clinical & Experimental Immunology, April 2005, Wiley

    Abdulrahmah S Hammond

  13. Quantitative T Cell Assay Reflects Infectious Load of Mycobacterium tuberculosis in an Endemic Case Contact Model

    Article • Clinical Infectious Diseases, January 2005, Oxford University Press (OUP)

    Abdulrahmah S Hammond

  14. Large‐Scale Evaluation of Enzyme‐Linked Immunospot Assay and Skin Test for Diagnosis of Mycobacterium tuberculosis Infection against a Gradient of Exposure in The Gambia

    Article • Clinical Infectious Diseases, April 2004, Oxford University Press (OUP)

    Abdulrahmah S Hammond, Moses Lugos

  15. HLA‐B*35–Restricted CD8 T Cell Epitopes in the Antigen 85 Complex of Mycobacterium tuberculosis

    Article • The Journal of Infectious Diseases, March 2001, Oxford University Press (OUP)

    Abdulrahmah S Hammond